1. Home
  2. NEPH vs VIVO Comparison

NEPH vs VIVO Comparison

Compare NEPH & VIVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.65

Market Cap

37.7M

Sector

Health Care

ML Signal

HOLD

VIVO

VivoPower PLC Ordinary Shares

N/A

Current Price

$6.28

Market Cap

37.5M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
NEPH
VIVO
Founded
1997
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
37.7M
37.5M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
NEPH
VIVO
Price
$3.65
$6.28
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
32.6K
1.8M
Earning Date
05-08-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
1000.00
N/A
EPS
0.01
N/A
Revenue
$18,789,000.00
N/A
Revenue This Year
$11.24
N/A
Revenue Next Year
$11.58
N/A
P/E Ratio
$369.50
N/A
Revenue Growth
32.67
N/A
52 Week Low
$2.66
$1.97
52 Week High
$6.42
$5.60

Technical Indicators

Market Signals
Indicator
NEPH
VIVO
Relative Strength Index (RSI) 57.72 72.56
Support Level $3.64 $2.87
Resistance Level $3.78 N/A
Average True Range (ATR) 0.28 0.73
MACD 0.03 0.15
Stochastic Oscillator 85.23 96.80

Price Performance

Historical Comparison
NEPH
VIVO

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: